Advertisement
YOU ARE HERE: KY3 HomeCollections

Earlier diagnosis and treatment is critical for psoriatic arthritis patients

July 26, 2011|from KY3 News

Golfer Phil Mickelson has openly talked about his experience with psoriatic arthritis. It's a type of arthritis unlike the others and can fuse joints, destroy bones, or both! 

Denise La Delia thought psoriasis was bad enough, then psoriatic arthritis appeared on the scene. She says it’s "a lot of pain, there's a lot of swelling.  My hands used to be real hot.  So, I'd be running them under cold water, taking cold baths because it was everywhere."   

La Delia manages to keep up with her career in spite of the joint disease. It's a condition that affects about a quarter of all psoriasis patients.  According to Dr. Christopher Ritchlin, "most of the patients develop psoriasis before the onset of arthritis. So, often times, there's a lag of 10 years between the onset of skin and joint disease."

Like rheumatoid arthritis, this condition destroys bone. In addition, it sets off exaggerated bone growth.

Advertisement

"And that new bone formation clinically presents as a fused joint, completely fused by bone either in the spine of in the peripheral joints," said Ritchlin.  

The doctor also says early diagnosis and treatment is critical to stave off irreversible damage.

"One of the things we're really focused on is trying to develop regimens of treatments that are simplified for the patient that can treat multiple different problems at one time: skin, joints, entheses, swollen digits, and also the spine," said Ritchlin.  

La Delia has benefited from biologic infusion therapy that helps manage both aspects of her condition.

"The type of medication, for some reason, helps out both things, the skin as well as the arthritis, so I'm very lucky."  

It's a dual-edged treatment that helps slow a dual-edged disease. 

Ritchlin, who is from the University of Rochester Medical Center, is conducting research to identify early markers of psoriatic arthritis. Within the next five years, they hope to be able to identify at-risk patients, which could lead to early or preventive treatment.

 

KY3 Articles
|
|
|